ENTITY
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals (GNP IN)

183
Analysis
Health Care • India
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company that develops, manufactures, and markets branded and generic formulations, active pharmaceutical ingredients (APIs), and over-the-counter (OTC) products. The company focuses on therapeutic areas including respiratory, dermatology, and oncology, with products such as Ryaltris, Winlevi, and Candid. It was founded in 1977 and is headquartered in Mumbai, India.
more
•04 Jun 2019 00:00

Asia HY Monthly - LARA And Credit Bias Study - Lucror Analytics

In this month’s “In-Focus” section, we discuss LARA and Credit Bias developments over the past few years for companies under our coverage,...

Logo
230 Views
Share
bullish•Fosun International
•30 May 2019 00:00

Lucror Analytics - Morning Views Asia - 30 May 2019

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...

Logo
184 Views
Share
•30 May 2019 00:00

Glenmark - Earnings Flash - FY 2018-19 Results - Lucror Analytics

Glenmark's Q4 and FY 2018-19 results were positive. The momentum in revenue growth was sustained in the final quarter (following a surprisingly...

Logo
137 Views
Share
•24 May 2019 00:00

Asia HY Trade Recommendations - May 2019 - Lucror Analytics

The Asia HY Trade Recommendations report for May includes a summary of our recommendations, as well as our high-conviction ideas. We also provide...

Logo
209 Views
Share
•02 May 2019 00:00

Asia HY Monthly - 2018 Results Overview (Ex-India) - Lucror Analytics

In this month’s “In-Focus” section, we discuss the 2018 results for Asian (ex-India) companies under our coverage, including whether or not they...

Logo
180 Views
Share
x